Stability testing and selection of final packaging for pravastatin tablets
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Poster
- By: LUSINA, Maja (PLIVA - Research Institute Ltd., Analytics, Zagreb, Croatia)
- Co-author(s): Jurlina (PLIVA - Research Institute Ltd., ZAGREB, Croatia)
Dumicic (PLIVA - Research Institute Ltd., ZAGREB, Croatia)
Dragic (PLIVA - Research Institute Ltd., ZAGREB, Croatia)
Within the drug development program of Pravastatin tablets 40 mg, stability testing is performed. It is known that pravastatin is sensitive to a low pH environment and to moisture and will degrade to form its lactone and other degradation products. Since formulation containing basic excipients is patent-protected, other ways of obtaining a.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.